Boston Scientific's Patent Suit Against J&J Heads To Jury
Boston Scientific, which lost two earlier trials to J&J over the lucrative technology, claims J&J's Cypher drug-eluting stent infringes its patents.
In closing arguments on Thursday, Patterson Belknap partner Gregory Diskant told the jury that Johnson & Johnson didn’t infringe Boston Scientific’s patents, which he said were invalid.
Already a subscriber? Click here to login